Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11382989
Engineered microbial population
granted -
US 11382899
Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
granted -
US 11377491
Anti-leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) monoclonal antibodies and method of use thereof to treat cancer
granted -
US 11376324
Sting activating nanovaccine for immunotherapy
granted -
US 11369716
Reparative cell isolation and delivery
granted -
US 11370786
GLS1 inhibitors for treating disease
granted -
US 11370769
TRPC5 inhibitors and methods of using same
granted -
US 11370757
Photocleavable nitroindoline-based crosslinkers
granted -
US 11369575
PPARα agonist compositions and methods of use
granted -
US 11365413
Inhibition of poly(A) binding protein and the treatment of pain
granted -
US 11364197
Compositions and methods of making brittle-matrix particles through blister pack freezing
granted -
US 11365189
Heterocyclic inhibitors of tyrosine kinase
granted -
US 11365250
Compositions and methods for cancer therapy
granted -
US 11365183
Eicosanoid derivatives
granted -
US 11357801
Methods for treating autism spectrum disorder and associated symptoms
granted -
US 11357848
Methods of rational nicotine hapten design and uses thereof
granted -
US 11358991
Heme sequesting peptides and uses therefor
granted -
US 11351153
Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent
granted -
US 11351264
PAR2 mimetic peptides and uses thereof
granted -
US 11344652
Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
granted -
US 11345659
Pipecolic esters for inhibition of the proteasome
granted -
US 11344577
Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted -
US 11344578
Immune cells expressing engineered antigen receptors
granted -
US 11345928
Modified immunization vectors
granted